![Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-021-00647-8/MediaObjects/41392_2021_647_Fig1_HTML.png)
Molecular mechanisms underpinning sarcomas and implications for current and future therapy | Signal Transduction and Targeted Therapy
![Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-12132-w/MediaObjects/41598_2017_12132_Fig1_HTML.jpg)
Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard | Scientific Reports
![The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-5163-2/MediaObjects/12885_2018_5163_Fig1_HTML.png)
The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov | BMC Cancer | Full Text
![Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/10071cf9-ff61-45d1-ad6a-963a4f288032/gr1.jpg)
Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma - Annals of Oncology
![Myxoid Liposarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis Myxoid Liposarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis](https://img.yumpu.com/38647496/1/500x640/myxoid-liposarcoma-global-clinical-trials-review-2015-market-trends-size-demand-cost-opportunity-analysis.jpg)
Myxoid Liposarcoma Global Clinical Trials Review 2015 Market Trends, Size, Demand, Cost, Opportunity Analysis
Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening | PLOS ONE
![Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/46a04ee9790c841bb1f691cde63f75a89c358e2d/3-Table1-1.png)
Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations | Semantic Scholar
Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening | PLOS ONE
![Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/244642bf-33f8-469a-a9ca-0d7de2d9cdb6/gr1_lrg.gif)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial - The Lancet Oncology
![Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/48c89712-2984-425e-b99c-0c395fb03e27/cam41958-fig-0001-m.jpg)
Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development - Lee - 2019 - Cancer Medicine - Wiley Online Library
![Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/a0df47c1-4246-451c-beb9-a2a01704e743/gr1_lrg.jpg)
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat](https://www.crstonline.com/articles/2018/1/2/images/CancerResStatTreat_2018_1_2_121_258547_f1.jpg)
Current treatment landscape and emerging management options for extremity sarcoma Turkar S - Cancer Res Stat Treat
![Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open](https://cyberleninka.org/viewer_images/1260895/f/1.png)
Novel Systemic Therapies in Advanced Liposarcoma: A Review of Recent Clinical Trial Results – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open
![Cureus | Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma Cureus | Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma](https://assets.cureus.com/uploads/figure/file/121087/lightbox_e175c020a14411eab8dc67254061205a-Figure-tiff.png)
Cureus | Hyperprogression of Liver Metastasis With Neoadjuvant Immunotherapy for Soft Tissue Sarcoma
![Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials - ESMO Open Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7d329d41-578a-4314-a684-3266ecfe5e93/gr1.jpg)
Early phase trials in soft-tissue sarcomas: clinical benefit of inclusion in early lines of treatment, molecular screening, and histology-driven trials - ESMO Open
![Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges | JCO Precision Oncology Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges | JCO Precision Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2022/po.2022.6/po.21.00211/20220404/images/large/po.21.00211t1.jpeg)